Piper Sandler Expands Healthcare Investment Banking Expertise
Piper Sandler Companies (NYSE: PIPR), a prominent name in investment banking, is excited to announce a significant addition to their healthcare investment banking team with the hiring of John Kerins as a managing director. This strategic move reflects the firm’s commitment to strengthening its presence in the rapidly evolving healthcare sector.
John Kerins Joins the Team
John Kerins brings a wealth of experience to Piper Sandler, having spent the last ten years at Cain Brothers & Company, where he served as a managing director on their healthcare team. His extensive background in advising clients on mergers and acquisitions positions him well to make a significant impact. Previously, Kerins also spent six years at Deloitte, providing comprehensive M&A advisory services. His educational credentials include a bachelor’s degree from Kenyon College and an MBA from the prestigious Fordham University Gabelli School of Business.
Enhancing Client Support
In his new role, Kerins will focus on assisting clients within the pharma services sector, contributing to the overall strength of the firm’s healthcare investment banking practice. J.P. Peltier, the global group head of healthcare investment banking, expressed enthusiasm about Kerins joining the team, highlighting his strong industry relationships and transaction experience. Peltier noted, "Pharma services is a rapidly growing segment of the market and a key focus for our healthcare investment banking platform. We are confident John’s skillset will enhance our ability to serve our clients and position Piper Sandler for long-term success in this market."
Looking Ahead in Healthcare Investment Banking
For Piper Sandler, the addition of John Kerins comes at a pivotal time when the healthcare sector is witnessing substantial growth and innovation. The firm's commitment to delivering exceptional service and expertise in this field is evident. Kerins himself expressed excitement about joining a team renowned for its leadership in mergers and acquisitions within the healthcare investment banking landscape. "I am thrilled to be joining Piper Sandler. Their healthcare investment banking team has a trusted reputation of M&A leadership in addition to their deep healthcare services and biopharma research presence," Kerins stated. He looks forward to collaborating with his new colleagues to continue providing top-notch client service.
About Piper Sandler Companies
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank dedicated to helping clients realize the power of partnership. The firm offers securities brokerage and investment banking services across the globe, including in the U.S., U.K., EU, and Hong Kong. Their extensive range of services encompasses alternative asset management and fixed income advisory services through various registered advisory affiliates. This wide-ranging expertise equips Piper Sandler to meet the complex needs of their clients in healthcare and beyond.
Frequently Asked Questions
What role will John Kerins play at Piper Sandler?
John Kerins will serve as a managing director focusing on the healthcare investment banking team, particularly in pharma services.
Why is the addition of John Kerins important for Piper Sandler?
Kerins brings valuable transaction experience and industry relationships that will enhance Piper Sandler's capabilities in healthcare investment banking.
What is Piper Sandler known for?
Piper Sandler is recognized for its expertise in investment banking, especially in healthcare mergers and acquisitions.
Where can I learn more about Piper Sandler?
For more information about Piper Sandler's services and teams, you can visit their official website.
What is the significance of the pharma services sector?
The pharma services sector is experiencing rapid growth, making it a key focus area for investment banking practices like that of Piper Sandler.
